Deloittes aims to flush out fast-moving biotechs
Wednesday, 06 March, 2002
National accounting firm Deloittes has launched its Technology Fast 50 program for 2002.
The program, now in its second year, aims to recognise and profile the 50 fastest-growing companies in Australia, based on percentage revenue growth over three years.
It covers all technology sectors, including biotech and IT.
Last year's Fast 50 featured imaging company Optiscan and medical instrument developer Polartechnics.
Deloittes client director David Black said that while some biotechnology companies would qualify for the Fast 50, most would be a better fit in the program's Rising Star category, "even the biotechs who feel they're not big company's because they don't have the revenue growth."
"It's designed to recognise and reward the companies that might not be big enough to hit the analysts' radars."
Winners of the Rising Star awards receive up to $5000 of support from Deloittes.
Nominations for the Fast 50 close on March 21. For more information, contact project manager Francois Van Der Merwe on (02) 9322 5828, or e-mail to fvandermerwe@deloitte.com.au
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
2026 Snow Fellowship recipients to receive $24m in biomedical funding
Australian biomedical researchers Dr Deborah Burnett, A/Prof Sudarshini Ramanathan and Dr Ira...
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
